Biosensor platforms solutions for quantitation: competition assays sector - Medical / Health Care
Competition assays are suitable for the detection of small molecules. In this detection scheme, the AuNPs-functionalized sensing surface is modified with target analytes. In a sensing event, a sample of free-flowing analytes are premixed with corresponding bioreceptors followed by introduction to the sensing surface. Free-flowing analytes and bound analytes then "compete" for binding with the bioreceptor. Binding of bioreceptor to the bound analyte results in an optical response.
Most popular related searches
Overview Applications and Industries
Target: methamphetamine (MA) in urine
Methamphetamine (MA) is a highly addictive stimulant drug. Abuse of this illicit drug can lead to an increased risk of contracting infectious diseases, extreme weight loss, severe dental problems, organ failure, or death.
A known concentration of MA is first functionalized onto the sensing surface. A sample of free-flowing MA with unknown concentration premixed with anti-MA antibodies is then introduced to the sensing surface. Bound MA and free-flowing MA “compete” for the anti-MA antibodies during detection. Binding of anti-MA antibodies to the bound MA results in a refractive index change at the sensing surface and produces an optical response.